![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
01 AVENTIS PHARMA S.A. (8)
02 Sanofi-Aventis (Suisse) SA (4)
03 ACCORD HEALTHCARE LIMITED (3)
04 AUROBINDO PHARMA ITALIA Srl (3)
05 Accord Healthcare Ltd. (3)
06 Actavis Group PTC ehf (3)
07 Actavis Switzerland AG (3)
08 Fresenius Kabi (Schweiz) AG (5)
09 HOSPIRA ITALIA Srl (3)
10 Hospira UK Limited (3)
11 Labatec Pharma SA (3)
12 MEDAC GMBH (3)
13 RATIOPHARM ITALIA Srl (3)
14 SANDOZ SpA (3)
15 Sandoz Pharmaceuticals AG (3)
16 Teva B.V. (2)
17 Teva Pharma AG (2)
18 The Fresenius Kabi Oncology Plc (5)
01 docetaxel trihydrate (62)
01 Italy (26)
02 Norway (16)
03 Switzerland (20)
01 Concentrate and liquid to the infusion fluid, resolution (2)
02 Concentrate to the infusion fluid (3)
03 Concentrate to the infusion fluid, resolution (11)
04 Docetaxl 140Mg 7Ml 1 Units Parenteral Use (3)
05 Docetaxl 160Mg 16Ml 1 Units Parenteral Use (2)
06 Docetaxl 160Mg 8Ml 1 Units Parenteral Use (3)
07 Docetaxl 20Mg 0,5Ml 1 Unit Parenteral Use (1)
08 Docetaxl 20Mg 1Ml 1 Units Parenteral Use (6)
09 Docetaxl 20Mg 2Ml 1 Units Parenteral Use (1)
10 Docetaxl 20Mg 2Ml 5 Units Parenteral Use (1)
11 Docetaxl 80Mg 2Ml 1 Units Parenteral Use (1)
12 Docetaxl 80Mg 4Ml 1 Units Parenteral Use (6)
13 Docetaxl 80Mg 8Ml 1 Units Parenteral Use (1)
14 Docetaxl 80Mg 8Ml 5 Units Parenteral Use (1)
15 Infusion (20)